Kidswell Bio Corporation
4584.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥13 | ¥13 | ¥5 | ¥4 |
| - Cash | ¥2 | ¥3 | ¥3 | ¥1 |
| + Debt | ¥1 | ¥2 | ¥2 | ¥2 |
| Enterprise Value | ¥13 | ¥12 | ¥4 | ¥5 |
| Revenue | ¥2 | ¥2 | ¥2 | ¥1 |
| % Growth | -9.6% | -15.9% | 59% | – |
| Gross Profit | ¥0 | ¥1 | ¥1 | ¥1 |
| % Margin | 25.4% | 34.7% | 29.8% | 41.8% |
| EBITDA | -¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | -5.1% | 10.8% | 7.4% | 9.1% |
| Net Income | -¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | -6.2% | 9.1% | 8.1% | 4.2% |
| EPS Diluted | -1.95 | 3.28 | 3.96 | 1.33 |
| % Growth | -159.5% | -17.2% | 197.7% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |